Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CELG, SIGA and SNTS

Accesswire July 17, 2013

Updates on Ongoing Clinical Trials and Retail Expansions - Research Report on Achillion, Medivation, ACADIA, Halozyme, and Charles River Laboratories

PR Newswire July 5, 2013

ACADIA Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference on July 9, 2013

Business Wire July 2, 2013

ACADIA Pharmaceuticals Added to Russell 2000 Index

Business Wire July 1, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, ACHN, CLDX and KERX

Accesswire June 24, 2013

Data Presentations, Orphan Drug Designations, FDA Applications and Reviews, Drug Market Expansion - Research Report on ACADIA Pharmaceuticals, ViroPharma, Santarus, Cytokinetics, and Exact Sciences

PR Newswire June 24, 2013

ACADIA Pharmaceuticals Announces Multiple Presentations of Data from Phase III Pimavanserin Program at the 17th International Congress of Parkinson's Disease and Movement Disorders

Business Wire June 18, 2013

StockCall Pre-Market Review on ACAD, DNDN, MDVN, CTIC, and SRPT

Accesswire June 13, 2013

Special Offer for Shareholders of ACAD, EMC, AAPL and YHOO

Marketwired June 11, 2013

Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma

PR Newswire June 10, 2013

InvestorsGuru.com 31 Filtered Mid-Day Market Movers Recap

Investors Guru June 8, 2013

ACADIA Pharmaceuticals Announces Advancement by Allergan of Novel Glaucoma Compound into Preclinical Development

Business Wire June 3, 2013

ACADIA Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 5, 2013

Business Wire May 29, 2013

ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock

Business Wire May 20, 2013

ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index

Business Wire May 20, 2013

Perfect Trade Setups, How to Play CLF, AUY, ACAD and DELL

Marketwired May 16, 2013

ACADIA Pharmaceuticals Prices Public Offering of Common Stock

Business Wire May 15, 2013

ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock

Business Wire May 14, 2013

Faruqi & Faruqi, LLP Launches An Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Business Wire May 10, 2013

ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results

Business Wire May 7, 2013